Detalhe da pesquisa
1.
Prostate-Specific Membrane Antigen: Gateway to Management of Advanced Prostate Cancer.
Annu Rev Med
; 75: 49-66, 2024 Jan 29.
Artigo
Inglês
| MEDLINE | ID: mdl-38285513
2.
Beyond PI-RADS: Combining MRI PI-RADS and PSMA-PET/CT PRIMARY Score in a Composite (P) Score for More Accurate Diagnosis of Clinically Significant Prostate Cancer.
J Urol
; : 101097JU0000000000004010, 2024 May 17.
Artigo
Inglês
| MEDLINE | ID: mdl-38758680
3.
FAPI PET uptake patterns after invasive medical interventions: a single center retrospective analysis.
Eur J Nucl Med Mol Imaging
; 2024 May 16.
Artigo
Inglês
| MEDLINE | ID: mdl-38750372
4.
Impact of PSMA PET on Prostate Cancer Management.
Curr Treat Options Oncol
; 25(2): 191-205, 2024 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-38270802
5.
Health-related quality of life and pain outcomes with [177Lu]Lu-PSMA-617 plus standard of care versus standard of care in patients with metastatic castration-resistant prostate cancer (VISION): a multicentre, open-label, randomised, phase 3 trial.
Lancet Oncol
; 24(6): 597-610, 2023 06.
Artigo
Inglês
| MEDLINE | ID: mdl-37269841
6.
Exploring new frontiers in prostate cancer research: Report from the 2022 Coffey-Holden prostate cancer academy meeting.
Prostate
; 83(3): 207-226, 2023 02.
Artigo
Inglês
| MEDLINE | ID: mdl-36443902
7.
Response Evaluation Criteria in PSMA PET/CT (RECIP 1.0) in Metastatic Castration-resistant Prostate Cancer.
Radiology
; 308(1): e222148, 2023 07.
Artigo
Inglês
| MEDLINE | ID: mdl-37432081
8.
Is PSMA PET/CT cost-effective for the primary staging in prostate cancer? First results for European countries and the USA based on the proPSMA trial.
Eur J Nucl Med Mol Imaging
; 50(12): 3750-3754, 2023 10.
Artigo
Inglês
| MEDLINE | ID: mdl-37428216
9.
PSMA PET/CT: joint EANM procedure guideline/SNMMI procedure standard for prostate cancer imaging 2.0.
Eur J Nucl Med Mol Imaging
; 50(5): 1466-1486, 2023 04.
Artigo
Inglês
| MEDLINE | ID: mdl-36604326
10.
Joint EANM/SNMMI procedure guideline for the use of 177Lu-labeled PSMA-targeted radioligand-therapy (177Lu-PSMA-RLT).
Eur J Nucl Med Mol Imaging
; 50(9): 2830-2845, 2023 07.
Artigo
Inglês
| MEDLINE | ID: mdl-37246997
11.
LUNAR: a randomized Phase 2 study of 177 Lutetium-PSMA Neoadjuvant to Ablative Radiotherapy for Oligorecurrent Prostate Cancer (clinical trial protocol).
BJU Int
; 132(1): 65-74, 2023 07.
Artigo
Inglês
| MEDLINE | ID: mdl-36797449
12.
Imaging Prostate Cancer: Clinical Utility of Prostate-Specific Membrane Antigen.
J Urol
; 207(4): 769-778, 2022 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-35085002
13.
Measuring response in metastatic castration-resistant prostate cancer using PSMA PET/CT: comparison of RECIST 1.1, aPCWG3, aPERCIST, PPP, and RECIP 1.0 criteria.
Eur J Nucl Med Mol Imaging
; 49(12): 4271-4281, 2022 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-35767071
14.
Nomograms to predict outcomes after 177Lu-PSMA therapy in men with metastatic castration-resistant prostate cancer: an international, multicentre, retrospective study.
Lancet Oncol
; 22(8): 1115-1125, 2021 08.
Artigo
Inglês
| MEDLINE | ID: mdl-34246328
15.
Prostate-specific Membrane Antigen PET in Prostate Cancer.
Radiology
; 299(2): 248-260, 2021 05.
Artigo
Inglês
| MEDLINE | ID: mdl-33787338
16.
Head-to-head intra-individual comparison of biodistribution and tumor uptake of 68Ga-FAPI and 18F-FDG PET/CT in cancer patients.
Eur J Nucl Med Mol Imaging
; 48(13): 4377-4385, 2021 12.
Artigo
Inglês
| MEDLINE | ID: mdl-34137945
17.
False positive PSMA PET for tumor remnants in the irradiated prostate and other interpretation pitfalls in a prospective multi-center trial.
Eur J Nucl Med Mol Imaging
; 48(2): 501-508, 2021 02.
Artigo
Inglês
| MEDLINE | ID: mdl-32808077
18.
Phase 3 multicenter randomized trial of PSMA PET/CT prior to definitive radiation therapy for unfavorable intermediate-risk or high-risk prostate cancer [PSMA dRT]: study protocol.
BMC Cancer
; 21(1): 512, 2021 May 07.
Artigo
Inglês
| MEDLINE | ID: mdl-33962579
19.
Meeting report from the Prostate Cancer Foundation PSMA theranostics state of the science meeting.
Prostate
; 80(15): 1273-1296, 2020 11.
Artigo
Inglês
| MEDLINE | ID: mdl-32865839
20.
PSMA-targeted Radiotracers versus 18F Fluciclovine for the Detection of Prostate Cancer Biochemical Recurrence after Definitive Therapy: A Systematic Review and Meta-Analysis.
Radiology
; 296(1): 44-55, 2020 07.
Artigo
Inglês
| MEDLINE | ID: mdl-32396045